Geron Corp. (GERN)

1.41
0.01 0.35
NASDAQ : Health Technology
Prev Close 1.41
Open 1.43
Day Low/High 1.40 / 1.45
52 Wk Low/High 0.95 / 6.99
Volume 988.59K
Avg Volume 1.66M
Exchange NASDAQ
Shares Outstanding 188.42M
Market Cap 261.91M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Today's Pre-Market Mover With Heavy Volume: Geron Corporation (GERN)

Today's Pre-Market Mover With Heavy Volume: Geron Corporation (GERN)

Trade-Ideas LLC identified Geron Corporation (GERN) as a pre-market mover with heavy volume candidate

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

Geron Corporation (GERN) In A Perilous Reversal

Geron Corporation (GERN) In A Perilous Reversal

Trade-Ideas LLC identified Geron Corporation (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Interesting GERN Put And Call Options For January 2014

Interesting GERN Put And Call Options For January 2014

Investors in Geron Corp. saw new options begin trading this week, for the January 2014 expiration.

Perilous Reversal Stock: Geron Corporation (GERN)

Perilous Reversal Stock: Geron Corporation (GERN)

Trade-Ideas LLC identified Geron Corporation (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Interesting GERN Call Options For January 2016

Interesting GERN Call Options For January 2016

Investors in Geron Corp. saw new options become available today, for the January 2016 expiration.

Interesting GERN Put And Call Options For January 2015

Interesting GERN Put And Call Options For January 2015

Investors in Geron Corp. saw new options become available today, for the January 2015 expiration.

Geron Corporation (GERN) Is Today's Perilous Reversal Stock

Geron Corporation (GERN) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Geron Corporation (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Geron's Imetelstat Data in Myelofibrosis: 4 CRs, 1 PR. But Are These Responses Real? (Update)

Geron's Imetelstat Data in Myelofibrosis: 4 CRs, 1 PR. But Are These Responses Real? (Update)

Gerons imetelstat might be the first myelofibrosis drug to treat the underlying cause of the disease, but it's not without controversy.

Today's Dead Cat Bounce Stock Is Geron Corporation (GERN)

Today's Dead Cat Bounce Stock Is Geron Corporation (GERN)

Trade-Ideas LLC identified Geron Corporation (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Geron: Super Important Imetelstat Data Coming Thursday

Geron: Super Important Imetelstat Data Coming Thursday

Investors will get their first look at key myelofibrosis data when ASH research abstracts are released.

First Week Of June 2014 Options Trading For Geron (GERN)

First Week Of June 2014 Options Trading For Geron (GERN)

Investors in Geron Corp. saw new options become available this week, for the June 2014 expiration.

Trade-Ideas: Geron Corporation (GERN) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Geron Corporation (GERN) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Geron Corporation (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Biotech Stocks Fall Most in Two Years Amidst Debt Ceiling Fears

Biotech Stocks Fall Most in Two Years Amidst Debt Ceiling Fears

Today's selling in the biotech sector will re-invigorate the debate about whether a bubble is about to pop.

Trade-Ideas: Geron Corporation (GERN) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Geron Corporation (GERN) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Geron Corporation (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Trade-Ideas: Geron Corporation (GERN) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Geron Corporation (GERN) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Geron Corporation (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Biotech Stock Mailbag: Celldex, Exelixis, Geron, NPS Pharma

Biotech Stock Mailbag: Celldex, Exelixis, Geron, NPS Pharma

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Short Interest Makes 31.3% Move For GERN

Short Interest Makes 31.3% Move For GERN

The most recent short interest data has been released by the NASDAQ for the 07/15/2013 settlement date, which shows a 1,043,800 share increase in total short interest for Geron Corp. , to 4,383,152, an increase of 31.26% since 06/28/2013.

Worried About Credit Risk? Check Out These 5 Cash-Rich Companies

Worried About Credit Risk? Check Out These 5 Cash-Rich Companies

Managing individual credit scores and risk is frustrating enough, but investors also need to consider the credit risk of a [...]

Short Interest Decreases By 18.3% For GERN

Short Interest Decreases By 18.3% For GERN

The most recent short interest data has been released by the NASDAQ for the 06/28/2013 settlement date, which shows a 746,207 share decrease in total short interest for Geron Corp. , to 3,339,352, a decrease of 18.26% since 06/14/2013.

Commit To Purchase Geron Corp. At $1, Earn 38% Annualized

Commit To Purchase Geron Corp. At $1, Earn 38% Annualized

Investors considering a purchase of Geron Corp. stock, but tentative about paying the going market price of $1.15/share, might benefit from considering selling puts among the alternative strategies at their disposal.

3 Health Care Stocks Under $10 to Watch

3 Health Care Stocks Under $10 to Watch

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

8 Stocks Under $10 Soaring Higher

8 Stocks Under $10 Soaring Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Ready to Break Out

5 Stocks Ready to Break Out

These stocks look poised to break out and trade higher from current levels

Stocks Slump as U.S. and Eurozone Uncertainties Fester

Stocks Slump as U.S. and Eurozone Uncertainties Fester

Still, Bank of America sees a year-end rally, according to technical analyst Mary Ann Bartels.

Stock Futures Point to Slightly Higher Wall Street Open

Stock Futures Point to Slightly Higher Wall Street Open

Stock futures are a touch higher Tuesday amid further signs of gridlock in talks over the 'fiscal cliff' in the U.S.

Stocks to Watch: Oracle, Geron, Knight, Big Lots (Update 1)

Stocks to Watch: Oracle, Geron, Knight, Big Lots (Update 1)

Oracle is accelerating its upcoming dividend payments for three quarters.

Morning Briefing: 10 Things You Should Know

Morning Briefing: 10 Things You Should Know

U.S. stock futures are flat to slightly higher; Oracle accelerates dividend payments; Qualcomm invests in Sharp; AutoZone and Pandora report earnings Tuesday.

A Weak Open On Wall Street As China Stumbles

A Weak Open On Wall Street As China Stumbles

Weak economic news from China, US weighs on stocks; Indexes slip head of Fed meeting

Geron's CEO Presents At Update On Imetelstat Clinical Development Program Conference (Transcript)

Geron's CEO Presents At Update On Imetelstat Clinical Development Program Conference (Transcript)

Geron's CEO Presents at Update on Imetelstat Clinical Development Program Conference (Transcript)

TheStreet Quant Rating: D (Sell)